VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $483,000 | +40.4% | 20,794 | -3.7% | 0.26% | +18.6% |
| Q1 2018 | $344,000 | +0.9% | 21,594 | +31.7% | 0.22% | -6.8% |
| Q4 2017 | $341,000 | +100.6% | 16,394 | +37.8% | 0.24% | +82.3% |
| Q3 2017 | $170,000 | -17.5% | 11,894 | 0.0% | 0.13% | -29.0% |
| Q2 2017 | $206,000 | +50.4% | 11,894 | -4.0% | 0.18% | +84.8% |
| Q1 2017 | $137,000 | -23.9% | 12,394 | 0.0% | 0.10% | -19.5% |
| Q4 2016 | $180,000 | – | 12,394 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |